Wolverine Trading, LLC Sage Therapeutics, Inc. Put Options Transaction History

Wolverine Trading, LLC

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 23, 2023	BUY	$40.65 - $59.54 $203,250 - $297,700	5,000 New	5,000 $235,000
Q4 2021 Feb 14, 2022	SELL	$37.06 - $47.11 $96,356 - $122,486	-2,600 Reduced 11.98%	19,100 $826,000
Q3 2021 Nov 12, 2021	SELL	$40.26 - $57.37 $454,938 - $648,281	-11,300 Reduced 34.24%	21,700 $958,000
Q2 2021 Aug 06, 2021	BUY	$54.88 - $79.29 $696,976 - $1.01 Million	12,700 Added 62.56%	33,000 $1.86 Million
Q1 2021 May 14, 2021	BUY	$70.65 - $96.76 $388,575 - $532,180	5,500 Added 37.16%	20,300 $1.49 Million

Q4 2020 Feb 12, 2021	BUY	$58.41 - $89.06 $46,728 - $71,248	800 Added 5.71%	14,800 $1.31 Million
Q3 2020 Nov 13, 2020	BUY	$41.13 - $62.45 $94,599 - $143,635	2,300 Added 19.66%	14,000 $835,000
Q2 2020 Aug 13, 2020	SELL	$25.95 - $43.15 $542,355 - $901,835	-20,900 Reduced 64.11%	11,700 $489,000
Q1 2020 May 11, 2020	BUY	$26.15 - $77.24 $852,490 - $2.52 Million	32,600 New	32,600 $962,000
Q1 2019 May 15, 2019	SELL	$89.33 - $163.65 $2.07 Million - $3.8 Million	-23,200 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$81.94 - $139.71 $81,940 - $139,710	1,000 Added 4.5%	23,200 $2.07 Million
Q3 2018 Nov 14, 2018	BUY	$138.11 - $169.04 $3.07 Million - $3.75 Million	22,200 New	22,200 $3.14 Million
Q1 2018 May 15, 2018	SELL	$152.15 - $192.33 $12.5 Million - $15.8 Million	-82,100 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$60.72 - $167.34 $3.25 Million - $8.97 Million	53,600 Added 188.07%	82,100 $13.5 Million
Q3 2017 Nov 15, 2017	BUY	$61.4 - $88.52 $1.75 Million - $2.52 Million	28,500	28,500 $1.78 Million

222

52.7M

207K

191K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $641M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.